Novo Nordisk A/S (NVO)

Novo Nordisk Cash Flow Statement

Financials in millions DKK. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	89,276	83,683	55,525	47,757	42,138	38,951
Depreciation & Amortization	10,608	9,413	7,362	6,025	5,753	5,661
Other Operating Activities	-6,476	15,812	16,000	1,218	4,060	2,170
Operating Cash Flow	93,408	108,908	78,887	55,000	51,951	46,782
Operating Cash Flow Growth	9.74%	38.06%	43.43%	5.87%	11.05%	4.85%
Capital Expenditures	-29,587	-25,806	-12,146	-6,335	-5,818	-8,928
Acquisitions	-	0	-7,075	-18,279	-374	-80
Change in Investments	9,815	-4,996	-3,090	-5,941	12	-202
Other Investing Activities	-13,517	-13,090	-2,607	-1,050	-16,256	-2,299
Investing Cash Flow	-33,289	-43,892	-24,918	-31,605	-22,436	-11,509
Dividends Paid	-41,987	-31,767	-25,303	-21,517	-20,121	-19,409
Share Issuance / Repurchase	-27,561	-29,924	-24,086	-19,447	-16,855	-15,334
Debt Issued / Paid	-1,306	-1,467	-2,408	15,471	4,732	-741
Other Financing Activities	1,935	-	-	-	-	-
Financing Cash Flow	-68,919	-63,158	-51,797	-25,493	-32,244	-35,484
Exchange Rate Effect	-119	-119	-238	591	-456	-7
Net Cash Flow	-8,612	1,739	1,934	-1,507	-3,185	-218
Free Cash Flow	63,821	83,102	66,741	48,665	46,133	37,854
Free Cash Flow Growth	-8.56%	24.51%	37.14%	5.49%	21.87%	8.18%
Free Cash Flow Margin	26.13%	35.78%	37.72%	34.56%	36.34%	31.02%
Free Cash Flow Per Share	14.15	18.22	14.76	10.62	9.78	7.72

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).